Cetridine may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Cetrimide is reported as an ingredient of Cetridine in the following countries:
Chlorhexidine digluconate (a derivative of Chlorhexidine) is reported as an ingredient of Cetridine in the following countries:
International Drug Name Search
Rino Calyptol may be available in the countries listed below.
Oxymetazoline hydrochloride (a derivative of Oxymetazoline) is reported as an ingredient of Rino Calyptol in the following countries:
International Drug Name Search
Roxonin may be available in the countries listed below.
Loxoprofen sodium salt (a derivative of Loxoprofen) is reported as an ingredient of Roxonin in the following countries:
International Drug Name Search
Micetinoftalmina may be available in the countries listed below.
Chloramphenicol is reported as an ingredient of Micetinoftalmina in the following countries:
International Drug Name Search
Ramipril/HCT Hexal may be available in the countries listed below.
Hydrochlorothiazide is reported as an ingredient of Ramipril/HCT Hexal in the following countries:
Ramipril is reported as an ingredient of Ramipril/HCT Hexal in the following countries:
International Drug Name Search
Prosulpin may be available in the countries listed below.
Sulpiride is reported as an ingredient of Prosulpin in the following countries:
International Drug Name Search
Molar Sodyum Bicarbonat may be available in the countries listed below.
Sodium Bicarbonate is reported as an ingredient of Molar Sodyum Bicarbonat in the following countries:
International Drug Name Search
Paclitaxel-ratiopharm may be available in the countries listed below.
Paclitaxel is reported as an ingredient of Paclitaxel-ratiopharm in the following countries:
International Drug Name Search
Bisacodyl Samenwerkende Apothekers may be available in the countries listed below.
Bisacodyl is reported as an ingredient of Bisacodyl Samenwerkende Apothekers in the following countries:
International Drug Name Search
Atenolol Teva may be available in the countries listed below.
Atenolol is reported as an ingredient of Atenolol Teva in the following countries:
International Drug Name Search
Fentanyl Citrato may be available in the countries listed below.
Fentanyl citrate (a derivative of Fentanyl) is reported as an ingredient of Fentanyl Citrato in the following countries:
International Drug Name Search
Eltocin may be available in the countries listed below.
Erythromycin estolate (a derivative of Erythromycin) is reported as an ingredient of Eltocin in the following countries:
International Drug Name Search
Ibupar may be available in the countries listed below.
Ibuprofen is reported as an ingredient of Ibupar in the following countries:
International Drug Name Search
Hitagen may be available in the countries listed below.
Chlorphenamine maleate (a derivative of Chlorphenamine) is reported as an ingredient of Hitagen in the following countries:
International Drug Name Search
Adapalène may be available in the countries listed below.
Adapalène (DCF) is known as Adapalene in the US.
International Drug Name Search
Glossary
| DCF | Dénomination Commune Française |
Furosemida Duncan may be available in the countries listed below.
Furosemide is reported as an ingredient of Furosemida Duncan in the following countries:
International Drug Name Search
Flutafin may be available in the countries listed below.
Acetylcysteine is reported as an ingredient of Flutafin in the following countries:
International Drug Name Search
Tebesium DUO may be available in the countries listed below.
Isoniazid is reported as an ingredient of Tebesium DUO in the following countries:
Rifampicin is reported as an ingredient of Tebesium DUO in the following countries:
International Drug Name Search
Moxar may be available in the countries listed below.
Mosapride citrate dihydrate (a derivative of Mosapride) is reported as an ingredient of Moxar in the following countries:
International Drug Name Search
Multiformil may be available in the countries listed below.
Nimesulide is reported as an ingredient of Multiformil in the following countries:
International Drug Name Search
Acemin may be available in the countries listed below.
Dexamethasone is reported as an ingredient of Acemin in the following countries:
Lisinopril dihydrate (a derivative of Lisinopril) is reported as an ingredient of Acemin in the following countries:
International Drug Name Search
Bumelex may be available in the countries listed below.
Bumetanide is reported as an ingredient of Bumelex in the following countries:
International Drug Name Search
Bisoltus may be available in the countries listed below.
Codeine hydrochloride (a derivative of Codeine) is reported as an ingredient of Bisoltus in the following countries:
International Drug Name Search
Piogtan may be available in the countries listed below.
Pioglitazone hydrochloride (a derivative of Pioglitazone) is reported as an ingredient of Piogtan in the following countries:
International Drug Name Search
Czopki Glicerynowe may be available in the countries listed below.
Glycerol is reported as an ingredient of Czopki Glicerynowe in the following countries:
International Drug Name Search
Glucodine W may be available in the countries listed below.
Chlorhexidine digluconate (a derivative of Chlorhexidine) is reported as an ingredient of Glucodine W in the following countries:
International Drug Name Search
Fluoxetin Alternova may be available in the countries listed below.
Fluoxetine hydrochloride (a derivative of Fluoxetine) is reported as an ingredient of Fluoxetin Alternova in the following countries:
International Drug Name Search
Larb Plus may be available in the countries listed below.
Hydrochlorothiazide is reported as an ingredient of Larb Plus in the following countries:
Losartan is reported as an ingredient of Larb Plus in the following countries:
International Drug Name Search
Tétamophile may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Colecalciferol is reported as an ingredient of Tétamophile in the following countries:
International Drug Name Search
Cipronatin may be available in the countries listed below.
Ciprofloxacin is reported as an ingredient of Cipronatin in the following countries:
International Drug Name Search
Pharken may be available in the countries listed below.
Pergolide mesilate (a derivative of Pergolide) is reported as an ingredient of Pharken in the following countries:
International Drug Name Search
Flossac may be available in the countries listed below.
Norfloxacin is reported as an ingredient of Flossac in the following countries:
International Drug Name Search
Cefotrial may be available in the countries listed below.
Cefotaxime is reported as an ingredient of Cefotrial in the following countries:
International Drug Name Search
Asmavent Inhalador may be available in the countries listed below.
Salbutamol is reported as an ingredient of Asmavent Inhalador in the following countries:
International Drug Name Search
Meitat may be available in the countries listed below.
Bisoprolol fumarate (a derivative of Bisoprolol) is reported as an ingredient of Meitat in the following countries:
International Drug Name Search
Cimetine may be available in the countries listed below.
Cimetidine is reported as an ingredient of Cimetine in the following countries:
International Drug Name Search
Cupripen may be available in the countries listed below.
Penicillamine is reported as an ingredient of Cupripen in the following countries:
International Drug Name Search
Phorpain may be available in the countries listed below.
Ibuprofen is reported as an ingredient of Phorpain in the following countries:
International Drug Name Search
Micotgez may be available in the countries listed below.
Miconazole nitrate (a derivative of Miconazole) is reported as an ingredient of Micotgez in the following countries:
International Drug Name Search
Eu-Med may be available in the countries listed below.
Dexibuprofen is reported as an ingredient of Eu-Med in the following countries:
Phenazone is reported as an ingredient of Eu-Med in the following countries:
International Drug Name Search
Amoclavs may be available in the countries listed below.
Amoxicillin is reported as an ingredient of Amoclavs in the following countries:
Clavulanic Acid is reported as an ingredient of Amoclavs in the following countries:
International Drug Name Search
Timolol Santen may be available in the countries listed below.
Timolol maleate (a derivative of Timolol) is reported as an ingredient of Timolol Santen in the following countries:
International Drug Name Search
Insulin Human may be available in the countries listed below.
Insulin Human (USAN) is also known as Insulin Injection, Soluble (Ph. Eur.)
International Drug Name Search
Glossary
| Ph. Eur. | European Pharmacopoeia |
| USAN | United States Adopted Name |
Renagel 800 mg film-coated tablets
Each tablet contains 800 mg sevelamer hydrochloride.
For a full list of excipients, see section 6.1.
Film-coated tablet (tablet)
The off-white, oval tablets are imprinted with “Renagel 800” on one side.
Renagel is indicated for the control of hyperphosphataemia in adult patients receiving haemodialysis or peritoneal dialysis. Renagel should be used within the context of a multiple therapeutic approach, which could include calcium supplements, 1,25 – dihydroxy Vitamin D3 or one of its analogues to control the development of renal bone disease.
Posology
Starting dose
The recommended starting dose of Renagel is 2.4 g or 4.8 g per day based on clinical needs and serum phosphorus level. Renagel must be taken three times per day with meals.
|
|
|
|
|
|
For patients previously on phosphate binders, Renagel should be given on a gram for gram basis with monitoring of serum phosphorus levels to ensure optimal daily doses.
Titration and maintenance
Serum phosphate levels should be closely monitored and the dose of Renagel adjusted accordingly with the goal of lowering serum phosphate to 1.76 mmol/l (5.5 mg/dl) or less. Serum phosphate should be tested every two to three weeks until a stable serum phosphate level is reached and on a regular basis thereafter.
The dose range may vary between 1 and 5 tablets of 800 mg per meal. The average actual daily dose used in the chronic phase of a one year clinical study was 7 grams of sevelamer.
Paediatric population
The safety and efficacy of this product has not been established in patients below the age of 18 years. Renagel is not recommended in children below the age of 18 years.
Renal impairment
The safety and efficacy of this product has not been established in predialysis patients. Renagel is not recommended in these patients.
Method of administration
For oral use
Patients should take Renagel with meals and adhere to their prescribed diets. The tablets must be swallowed whole. Do not chew.
• Hypersensitivity to sevelamer or to any of the excipients..
• Hypophosphataemia
• Bowel obstruction.
Efficacy and safety of Renagel has not been studied in patients with:
• swallowing disorders
• active inflammatory bowel disease
• gastrointestinal motility disorders including untreated or severe gastroparesis, diverticulosis, retention of gastric contents and abnormal or irregular bowel motion
• patients with a history of major gastrointestinal surgery
Therefore caution should be exercised when Renagel is used in patients with these disorders.
Intestinal obstruction and ileus/subileus
In very rare cases, intestinal obstruction and ileus/subileus have been observed in patients during treatment with Renagel. Constipation may be a preceding symptom. Patients who are constipated should be monitored carefully while being treated with Renagel. Renagel treatment should be re-evaluated in patients who develop severe constipation or other severe gastrointestinal symptoms.
Fat-soluble vitamins
Depending on diet intake and the nature of end stage renal failure, dialysis patients may develop low vitamin A, D, E and K levels. It cannot be excluded that Renagel can bind fat
Folate deficiency
There is at present insufficient data to exclude the possibility of folate deficiency during long term Renagel treatment.
Hypocalcaemia/hypercalcaemia
Patients with renal insufficiency may develop hypocalcaemia or hypercalcaemia. Renagel does not contain calcium. Serum calcium levels should be monitored as is done in normal follow-up of a dialysis patient. Elemental calcium should be given as a supplement in case of hypocalcaemia.
Metabolic acidosis
Patients with chronic renal failure are predisposed to developing metabolic acidosis. Worsening of acidosis has been reported upon switching from other phosphate binders to sevelamer in a number of studies where lower bicarbonate levels in the sevelamer-treated patients compared to patients treated with calcium-based binders were observed. Closer monitoring of serum bicarbonate levels is therefore recommended.
Peritonitis
Patients receiving dialysis are subject to certain risks for infection specific to the dialysis modality. Peritonitis is a known complication in patients receiving peritoneal dialysis (PD) and in a clinical study with Renagel, a number of peritonitis cases were reported. Therefore, patients on PD should be closely monitored to ensure the reliable use of appropriate aseptic technique with the prompt recognition and management of any signs and symptoms associated with peritonitis.
Anti-arrhythmic and anti-seizure medicinal products
Caution should be exercised when prescribing Renagel to patients also taking anti
Hypothyroidism
Closer monitoring of patients with hypothyroidism co-administered with sevelamer hydrochloride and levothryroxine is recommended (see section 4.5).
Long term chronic treatment
As data on the chronic use of sevelamer for over one year are not yet available, potential absorption and accumulation of sevelamer during long-term chronic treatment cannot be totally excluded (see section 5.2 Pharmacokinetics).
Hyperparathyroidism
Renagel alone is not indicated for the control of hyperparathyroidism. In patients with secondary hyperparathyroidism Renagel should be used within the context of a multiple therapeutic approach, which could include calcium supplements, 1,25 - dihydroxy Vitamin D3 or one of its analogues to lower the intact parathyroid hormone (iPTH) levels.
Serum chloride
Serum chloride may increase during Renagel treatment as chloride may be exchanged for phosphorus in the intestinal lumen. Although no clinically significant serum chloride increase has been observed in the clinical studies, serum chloride should be monitored as is done in the routine follow-up of a dialysis patient. One gram of Renagel contains approximately 180 mg (5.1mEq) chloride.
Interaction studies have not been conducted in patients on dialysis.
In interaction studies in healthy volunteers, Renagel decreased the bioavailability of ciprofloxacin by approximately 50% when co-administered with Renagel in a single dose study. Consequently, Renagel should not be taken simultaneously with ciprofloxacin.
Patients taking anti-arrhythmic medications for the control of arrhythmias and anti-seizure medications for the control of seizure disorders were excluded from clinical trials. Caution should be exercised when prescribing Renagel to patients also taking these medications.
During post marketing experience, very rare cases of increased TSH levels have been reported in patients co-administered Renagel and levothyroxine. Closer monitoring of TSH levels is therefore recommended in patients receiving both medications.
Reduced levels of ciclosporin, mycophenolate mofetil and tacrolimus have been reported in transplant patients when coadministered with Renagel without any clinical consequences (i.e graft rejection). The possibility of an interaction cannot be excluded and a close monitoring of blood concentrations of mycophenolate mofetil, ciclosporin and tacrolimus should be considered during the use of combination and after its withdrawal.
In interaction studies in healthy volunteers, Renagel had no effect on the bioavailability of digoxin, warfarin, enalapril or metoprolol.
Renagel is not absorbed and may affect the bioavailability of other medicinal products. When administering any medicinal product where a reduction in the bioavailability could have a clinically significant effect on safety or efficacy, the medicinal product should be administered at least one hour before or three hours after Renagel, or the physician should consider monitoring blood levels.
Pregnancy:
The safety of Renagel has not been established in pregnant women. In animal studies there was no evidence that sevelamer induced embryo-foetal toxicity. Renagel should only be given to pregnant women if clearly needed and after a careful risk/benefit analysis has been conducted for both the mother and the foetus (See 5.3 Preclinical safety data).
Lactation:
The safety of Renagel has not been established in lactating women. Renagel should only be given to lactating women if clearly needed and after a careful risk/benefit analysis has been conducted for both the mother and the infant (See 5.3 Preclinical safety data).
No studies on the effects on ability to drive and use machines have been performed.
In parallel design studies involving 244 haemodialysis patients with treatment duration of up to 54 weeks and 97 peritoneal dialysis patients with treatment duration of 12 weeks, the most frequently occurring (
|
|
|
Post-marketing experience: During post-approval use of Renagel, cases of pruritus, rash, abdominal pain, intestinal obstruction, ileus/subileus, diverticulitis and intestinal perforation have been reported.
No case of overdose has been reported.
Renagel has been given to normal healthy volunteers in doses up to 14 grams, the equivalent of seventeen 800 mg tablets, per day for eight days with no undesirable effects.
Treatment of hyperphosphatemia. ATC code: V03AE02.
Renagel contains sevelamer, a non-absorbed phosphate binding poly(allylamine hydrochloride) polymer, free of metal and calcium. It contains multiple amines separated by one carbon from the polymer backbone. These amines become partially protonated in the intestine and interact with phosphate molecules through ionic and hydrogen bonding. By binding phosphate in the gastrointestinal tract, sevelamer lowers the phosphate concentration in the serum.
In clinical trials, selevamer has been shown to be effective in reducing serum phosphorus in patients receiving haemodialysis or peritoneal dialysis.
Sevelamer decreases the incidence of hypercalcaemic episodes as compared to patients using calcium based phosphate binders alone, probably because the product itself does not contain calcium. The effects on phosphate and calcium were proven to be maintained throughout a study with one year follow-up.
Sevelamer has been shown to bind bile acids in vitro and in vivo in experimental animal models. Bile acid binding by ion exchange resins is a well-established method of lowering blood cholesterol. In clinical trials mean total and LDL cholesterol declined by 15-31%. This effect is observed after 2 weeks is maintained with long-term treatment. Triglycerides, HDL cholesterol and albumin did not change.
In the clinical studies in haemodialysis patients, sevelamer alone did not have a consistent and clinically significant effect on serum intact parathyroid hormone (iPTH). In the 12 week study involving peritoneal dialysis patients however, similar iPTH reductions were seen compared with patients receiving calcium acetate. In patients with secondary hyperparathyroidism Renagel should be used within the context of a multiple therapeutic approach, which could include calcium supplements, 1,25 – dihydroxy Vitamin D3 or one of its analogues to lower the intact parathyroid hormone (iPTH) levels.
In a clinical trial of one-year duration, Renagel had no adverse effect on bone turnover or mineralisation compared to calcium carbonate.
Renagel is not absorbed from the gastrointestinal tract according to a single dose pharmacokinetic study in healthy volunteers. Pharmacokinetic studies have not been carried out in renal failure patients (see section 4.4 Special warnings and special precautions for use).
In preclinical studies in rats and dogs, Renagel at a dose of 10 times the maximum human doses reduced absorption of fat soluble vitamins D, E and K, and folic acid.
In a study in rats, administering sevelamer in 15-30 x the human dose, an increase in serum copper was detected. This was not confirmed in a dog study or in clinical trials.
Currently, no formal carcinogenicity data are available. However, in vitro and in vivo studies have indicated that Renagel does not have genotoxic potential. Also the medicinal product is not absorbed in the gastrointestinal tract.
In reproduction studies there was no evidence that sevelamer induced embryolethality, foetotoxicity or teratogenicity at the doses tested (up to 1 g/kg/day in rabbits and up to 4.5 g/kg/day in rats). Deficits in skeletal ossification were observed in several locations in fetuses of female rats dosed with sevelamer at 8-20 times the maximum human dose of 200 mg/kg. The effects may be secondary to vitamin D and/or vitamin K depletion at these high doses.
Tablet core:
Silica, colloidal anhydrous
Stearic acid
Film-coating:
Hypromellose
Diacetylated monoglycerides
Printing ink:
Iron oxide black (E172)
Propylene glycol
Hypromellose
Not applicable
3 years
Do not store above25ºC.
Keep the bottle tightly closed in order to protect from moisture.
HDPE bottles, with a child resistant polypropylene cap and a foil induction seal.
Package sizes are:
6 bottles of 30 tablets
1bottle of 100 tablets
1 bottle of 180 tablets
2 bottles of 180 tablets
3 bottles of 180 tablets
Not all pack sizes may be marketed.
No special requirements.
Genzyme Europe B.V., Gooimeer 10, 1411 DD Naarden, The Netherlands
EU/1/99/123/008
EU/1/99/123/009
EU/1/99/123/010
EU/1/99/123/011
EU/1/99/123/012
EU/1/99/123/013
Date of first authorisation: 28/01/2000
Renewal date: 02/02/2010
06/2010
Detailed information on this medicinal product is available on the website of the European Medicines Agency (EMEA) http://www.emea.europa.eu/.
In the US, Pataday (olopatadine ophthalmic) is a member of the drug class ophthalmic antihistamines and decongestants and is used to treat Seasonal Allergic Conjunctivitis.
US matches:
Olopatadine hydrochloride (a derivative of Olopatadine) is reported as an ingredient of Pataday in the following countries:
International Drug Name Search
Mebamox may be available in the countries listed below.
Mebendazole is reported as an ingredient of Mebamox in the following countries:
International Drug Name Search
Profinject may be available in the countries listed below.
Ketoprofen is reported as an ingredient of Profinject in the following countries:
International Drug Name Search
In some countries, this medicine may only be approved for veterinary use.
In the US, Asacol (mesalamine systemic) is a member of the drug class 5-aminosalicylates and is used to treat Crohn's Disease - Maintenance, Lymphocytic Colitis, Ulcerative Colitis - Active and Ulcerative Colitis - Maintenance.
US matches:
UK matches:
Mesalazine is reported as an ingredient of Asacol in the following countries:
International Drug Name Search
Glossary
| SPC | Summary of Product Characteristics (UK) |
Pamedox may be available in the countries listed below.
Ampicillin trihydrate (a derivative of Ampicillin) is reported as an ingredient of Pamedox in the following countries:
International Drug Name Search
Lisinopril Normon may be available in the countries listed below.
Lisinopril dihydrate (a derivative of Lisinopril) is reported as an ingredient of Lisinopril Normon in the following countries:
International Drug Name Search
Medazol may be available in the countries listed below.
Metronidazole is reported as an ingredient of Medazol in the following countries:
International Drug Name Search
Cefotaxima Teva may be available in the countries listed below.
Cefotaxime sodium salt (a derivative of Cefotaxime) is reported as an ingredient of Cefotaxima Teva in the following countries:
International Drug Name Search
B12-AS may be available in the countries listed below.
Calcitonin acetate (a derivative of Calcitonin) is reported as an ingredient of B12-AS in the following countries:
International Drug Name Search
Lafigesic may be available in the countries listed below.
Clonixin lysine salt (a derivative of Clonixin) is reported as an ingredient of Lafigesic in the following countries:
International Drug Name Search
Ibuprofeno Stada may be available in the countries listed below.
Ibuprofen is reported as an ingredient of Ibuprofeno Stada in the following countries:
International Drug Name Search
Ibuprofeno Infarmasa may be available in the countries listed below.
Ibuprofen is reported as an ingredient of Ibuprofeno Infarmasa in the following countries:
International Drug Name Search
Betahistin AL may be available in the countries listed below.
Betahistine dimesilate (a derivative of Betahistine) is reported as an ingredient of Betahistin AL in the following countries:
International Drug Name Search
In the US, Alli (orlistat systemic) is a member of the drug class peripherally acting antiobesity agents and is used to treat Obesity.
US matches:
UK matches:
Orlistat is reported as an ingredient of Alli in the following countries:
International Drug Name Search
Glossary
| SPC | Summary of Product Characteristics (UK) |
Cefurox Basics may be available in the countries listed below.
Cefuroxime axetil (a derivative of Cefuroxime) is reported as an ingredient of Cefurox Basics in the following countries:
International Drug Name Search
Citidoline may be available in the countries listed below.
Citidoline (DCF) is known as Citicoline in the US.
International Drug Name Search
Glossary
| DCF | Dénomination Commune Française |
Pacetcool may be available in the countries listed below.
Cefotiam dihydrochloride (a derivative of Cefotiam) is reported as an ingredient of Pacetcool in the following countries:
International Drug Name Search
Pektolin may be available in the countries listed below.
Diphenhydramine is reported as an ingredient of Pektolin in the following countries:
International Drug Name Search
Mangafodipir Trisodium may be available in the countries listed below.
Mangafodipir Trisodium (BANM, USAN) is known as Mangafodipir in the US.
International Drug Name Search
Glossary
| BANM | British Approved Name (Modified) |
| USAN | United States Adopted Name |
Lafarin may be available in the countries listed below.
Cefalexin is reported as an ingredient of Lafarin in the following countries:
International Drug Name Search
Bleomycin Baxter may be available in the countries listed below.
Bleomycin sulfate (a derivative of Bleomycin) is reported as an ingredient of Bleomycin Baxter in the following countries:
International Drug Name Search
Eraxil may be available in the countries listed below.
Crotamiton is reported as an ingredient of Eraxil in the following countries:
International Drug Name Search
AteHexal comp may be available in the countries listed below.
Atenolol is reported as an ingredient of AteHexal comp in the following countries:
Chlortalidone is reported as an ingredient of AteHexal comp in the following countries:
International Drug Name Search
Albendazol Genfar may be available in the countries listed below.
Albendazole is reported as an ingredient of Albendazol Genfar in the following countries:
International Drug Name Search
PMS-Valproic Acid may be available in the countries listed below.
Valproic Acid is reported as an ingredient of PMS-Valproic Acid in the following countries:
International Drug Name Search
Loratadina Fecofar may be available in the countries listed below.
Loratadine is reported as an ingredient of Loratadina Fecofar in the following countries:
International Drug Name Search
In some countries, this medicine may only be approved for veterinary use.
Bacitracin methylene disalicylate (a derivative of Bacitracin) is reported as an ingredient of Fortracin in the following countries:
Lasalocid is reported as an ingredient of Fortracin in the following countries:
International Drug Name Search
Myco-Decidin may be available in the countries listed below.
Undecylenic Acid is reported as an ingredient of Myco-Decidin in the following countries:
International Drug Name Search
Memopil may be available in the countries listed below.
Piracetam is reported as an ingredient of Memopil in the following countries:
International Drug Name Search
Crotamitex may be available in the countries listed below.
Crotamiton is reported as an ingredient of Crotamitex in the following countries:
International Drug Name Search
In the US, Chibroxin (norfloxacin ophthalmic) is a member of the drug class ophthalmic anti-infectives and is used to treat Conjunctivitis and Ophthalmic Surgery.
US matches:
Norfloxacin is reported as an ingredient of Chibroxin in the following countries:
International Drug Name Search
In the US, Azmacort (triamcinolone systemic) is a member of the following drug classes: glucocorticoids, inhaled corticosteroids and is used to treat Asthma.
US matches:
Triamcinolone 16α,17α-acetonide (a derivative of Triamcinolone) is reported as an ingredient of Azmacort in the following countries:
International Drug Name Search
Alegain may be available in the countries listed below.
Epinastine hydrochloride (a derivative of Epinastine) is reported as an ingredient of Alegain in the following countries:
International Drug Name Search
Ibuprofeno Ilab may be available in the countries listed below.
Ibuprofen is reported as an ingredient of Ibuprofeno Ilab in the following countries:
International Drug Name Search
Benoxi Unimed Pharma may be available in the countries listed below.
Oxybuprocaine hydrochloride (a derivative of Oxybuprocaine) is reported as an ingredient of Benoxi Unimed Pharma in the following countries:
International Drug Name Search
Petnidan may be available in the countries listed below.
Ethosuximide is reported as an ingredient of Petnidan in the following countries:
International Drug Name Search
Apo-Benazepril may be available in the countries listed below.
Benazepril hydrochloride (a derivative of Benazepril) is reported as an ingredient of Apo-Benazepril in the following countries:
International Drug Name Search
Prednisone Almus may be available in the countries listed below.
Prednisone is reported as an ingredient of Prednisone Almus in the following countries:
International Drug Name Search
Absenor may be available in the countries listed below.
Valproic Acid semisodium (a derivative of Valproic Acid) is reported as an ingredient of Absenor in the following countries:
Valproic Acid sodium (a derivative of Valproic Acid) is reported as an ingredient of Absenor in the following countries:
International Drug Name Search
Benzafibrat Hexal may be available in the countries listed below.
Bezafibrate is reported as an ingredient of Benzafibrat Hexal in the following countries:
International Drug Name Search
Lacobile may be available in the countries listed below.
Ubidecarenone is reported as an ingredient of Lacobile in the following countries:
International Drug Name Search
Espironolactona AC Farma may be available in the countries listed below.
Spironolactone is reported as an ingredient of Espironolactona AC Farma in the following countries:
International Drug Name Search
Chlorhexidine digluconate (a derivative of Chlorhexidine) is reported as an ingredient of Cida-Stat in the following countries:
International Drug Name Search
Epitomax Orifarm may be available in the countries listed below.
Topiramate is reported as an ingredient of Epitomax Orifarm in the following countries:
International Drug Name Search
Busansil may be available in the countries listed below.
Buspirone hydrochloride (a derivative of Buspirone) is reported as an ingredient of Busansil in the following countries:
International Drug Name Search
Biso-Puren comp may be available in the countries listed below.
Bisoprolol fumarate (a derivative of Bisoprolol) is reported as an ingredient of Biso-Puren comp in the following countries:
Hydrochlorothiazide is reported as an ingredient of Biso-Puren comp in the following countries:
International Drug Name Search
Lofatin may be available in the countries listed below.
Cefoxitin sodium salt (a derivative of Cefoxitin) is reported as an ingredient of Lofatin in the following countries:
International Drug Name Search
Polhumin MIX-3 may be available in the countries listed below.
Insulin Injection, Biphasic Isophane human (a derivative of Insulin Injection, Biphasic Isophane) is reported as an ingredient of Polhumin MIX-3 in the following countries:
International Drug Name Search
Fundan may be available in the countries listed below.
Ketoconazole is reported as an ingredient of Fundan in the following countries:
International Drug Name Search
Tafenil may be available in the countries listed below.
Flutamide is reported as an ingredient of Tafenil in the following countries:
International Drug Name Search
USP
0007758-11-4
K2-H-P-O4
174
Pharmaceutic aid
Calcium regulator
Electrolyte solution
Dikaliumhydrogenphosphat (IUPAC)
Dipotassium hydrogen orthophosphate (The Merck Index)
Dipotassium hydrogen phosphate (USAN, USP)
Phosphoric acid, dipotassium salt (USAN, USP)
International Drug Name Search
Glossary
| IUPAC | International Union of Pure and Applied Chemistry |
| IS | Inofficial Synonym |
| JAN | Japanese Accepted Name |
| OS | Official Synonym |
| PH | Pharmacopoeia Name |
| USAN | United States Adopted Name |
| USP | Pharmacopoeia of the United States |
MDB Supalint may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Niclosamide is reported as an ingredient of MDB Supalint in the following countries:
International Drug Name Search
Chimono may be available in the countries listed below.
Lomefloxacin hydrochloride (a derivative of Lomefloxacin) is reported as an ingredient of Chimono in the following countries:
International Drug Name Search
Chlortétracycline may be available in the countries listed below.
Chlortétracycline (DCF) is known as Chlortetracycline in the US.
International Drug Name Search
Glossary
| DCF | Dénomination Commune Française |
Topifort may be available in the countries listed below.
Clobetasol 17α-propionate (a derivative of Clobetasol) is reported as an ingredient of Topifort in the following countries:
International Drug Name Search
Iesef may be available in the countries listed below.
Ceftriaxone disodium salt (a derivative of Ceftriaxone) is reported as an ingredient of Iesef in the following countries:
International Drug Name Search
Losartan Postasico Calox may be available in the countries listed below.
Losartan potassium salt (a derivative of Losartan) is reported as an ingredient of Losartan Postasico Calox in the following countries:
International Drug Name Search
Endogel may be available in the countries listed below.
Hyaluronic Acid sodium salt (a derivative of Hyaluronic Acid) is reported as an ingredient of Endogel in the following countries:
International Drug Name Search
Mirtazapine Actavis may be available in the countries listed below.
Mirtazapine is reported as an ingredient of Mirtazapine Actavis in the following countries:
International Drug Name Search
Instana may be available in the countries listed below.
Cefpodoxime proxetil (a derivative of Cefpodoxime) is reported as an ingredient of Instana in the following countries:
International Drug Name Search
In some countries, this medicine may only be approved for veterinary use.
In the US, Amiodarone (amiodarone systemic) is a member of the drug class group III antiarrhythmics and is used to treat Arrhythmia, Ventricular Fibrillation and Ventricular Tachycardia.
US matches:
UK matches:
Rec.INN
C01BD01
0001951-25-3
C25-H29-I2-N-O3
645
Coronary vasodilator
Methanone, (2-butyl-3-benzofuranyl)[4-[2-(diethylamino)ethoxy]-3,5-diiodophenyl]-
International Drug Name Search
Glossary
| BAN | British Approved Name |
| BANM | British Approved Name (Modified) |
| DCF | Dénomination Commune Française |
| DCIT | Denominazione Comune Italiana |
| IS | Inofficial Synonym |
| JAN | Japanese Accepted Name |
| OS | Official Synonym |
| PH | Pharmacopoeia Name |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| SPC | Summary of Product Characteristics (UK) |
| USAN | United States Adopted Name |
